HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kayo Yamada Selected Research

Philadelphia Chromosome

8/2013Feasibility of reduced-intensity allogeneic stem cell transplantation with imatinib in children with philadelphia chromosome-positive acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kayo Yamada Research Topics

Disease

1Epstein-Barr Virus Infections
02/2014
1Hypoxia (Hypoxemia)
08/2013
1Philadelphia Chromosome
08/2013
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2013
1Neoplasms (Cancer)
03/2013
1Juvenile Xanthogranuloma
02/2012
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
02/2012
1Bone Marrow Failure Disorders
02/2012
1Genomic Instability
07/2011
1Choriocarcinoma
06/2006

Drug/Important Bio-Agent (IBA)

2Tumor Suppressor Protein p14ARF (p14ARF)IBA
08/2013 - 03/2013
1Imatinib Mesylate (Gleevec)FDA Link
08/2013
1Nuclear Proteins (Protein, Nuclear)IBA
03/2013
1Proteins (Proteins, Gene)FDA Link
03/2013
1CladribineFDA LinkGeneric
02/2012
1Replication Protein C (Replication Factor C)IBA
07/2011
1Basic Helix-Loop-Helix Transcription FactorsIBA
06/2006

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2014
1Hematopoietic Stem Cell Transplantation
02/2014
1Stem Cell Transplantation
08/2013
1Therapeutics
02/2012
1Salvage Therapy
02/2012